All Stories

  1. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

    Article • Journal of Medical Economics, August 2019, Taylor & Francis

    Professor Stephen Charles Bain, Mr Barrie D Chubb, Brian Bekker Hansen, Barnaby Hunt, Emma McBeath

  2. Clinical inertia in basal insulin-treated patients with type 2 diabetes – Results from a retrospective database study in Japan (JDDM 43)

    Article • PLoS ONE, September 2018, PLOS

    Brian Bekker Hansen

  3. Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective

    Article • Diabetes Therapy, August 2016, Springer Science + Business Media

    Brian Bekker Hansen

  4. The Economic and Health-related Impact of Crohnʼs Disease in the United States

    Article • Inflammatory Bowel Diseases, May 2016, Oxford University Press (OUP)

    Brian Bekker Hansen

  5. PROMs for Systemic Lupus Erythematosus

    Article • January 2016, Springer Science + Business Media

    Brian Bekker Hansen

  6. Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial

    Article • Arthritis & Rheumatology, May 2015, Wiley

    Brian Bekker Hansen, Ladislav Senolt

  7. Key data elements for use in cost-utility modeling of biological treatments for rheumatoid arthritis

    Article • Journal of Medical Economics, January 2015, Informa Healthcare

    Michael Ganz, Brian Bekker Hansen

  8. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance

    Article • Health and Quality of Life Outcomes, July 2014, Springer Science + Business Media

    Brian Bekker Hansen

  9. Linguistic Validation into 20 Languages and Content Validity of the Rheumatoid Arthritis-Specific Work Productivity and Activity Impairment Questionnaire

    Article • The Patient Patient-Centered Outcomes Research, March 2014, Springer Science + Business Media

    Brian Bekker Hansen

  10. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials

    Article • The Clinical Respiratory Journal, July 2009, Wiley

    Brian Bekker Hansen